BioXcel Therapeutics, Inc. reports

Company location: New Haven, CT
Fiscal year end: 31 December

BioXcel Therapeutics, Inc. has filed 656 SEC EDGAR filings since 13 Nov 2017

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 326-350 of 656 matching filings.

Per page

25

Current page

14

3

FORM 3

Filing date: 13 Apr 2023
Reporting date: 03 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 13 Apr 2023
Reporting date: 03 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 13 Apr 2023
Reporting date: 03 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 13 Apr 2023
Reporting date: 03 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 13 Apr 2023
Reporting date: 03 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 13 Apr 2023
Reporting date: 03 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 13 Apr 2023
Reporting date: 03 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 13 Apr 2023
Reporting date: 03 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 13 Apr 2023
Reporting date: 03 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 13 Apr 2023
Reporting date: 03 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 13 Apr 2023
Reporting date: 03 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 13 Apr 2023
Reporting date: 03 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 13 Apr 2023
Reporting date: 03 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 13 Apr 2023
Reporting date: 03 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 10 Apr 2023
Reporting date: 06 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-90437

SC 13G/A

Filing date: 04 Apr 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 22 Mar 2023
Reporting date: 20 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-270652

FORM S-8

Filing date: 17 Mar 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 16 Mar 2023
Reporting date: 14 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 16 Mar 2023
Reporting date: 14 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 16 Mar 2023
Reporting date: 14 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 16 Mar 2023
Reporting date: 14 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 16 Mar 2023
Reporting date: 15 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 16 Mar 2023
Reporting date: 14 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38410

FORM 8-K

Filing date: 16 Mar 2023
Reporting date: 16 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .